jim in pennsylvania

Dendreon: Provenge's Shortcomings Have the Shorts Coming

kapur------------ such ramblings---------- where did u get ur information that the ceo sold over half his stock?
the very idea that the fda will not approve is absurd! men in there last days with prostate
cancer will have a chance to live longer with hardly any side effects.
my bet is the fda has no choice but to approve for the sake of those suffering last stages of prostate cancer. WHAT DO THEY HAVE TO LOSE?